Download PDF

Other users also viewed these articles

Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology Alejandro Balsa; Daniel Seoane-Mato; Marta Domínguez-Álvaro; Mercedes Alperi; Virginia Ruiz-Esquide; Javier Bachiller-Corral; Federico Díaz-González;
10.1016/j.reumae.2025.501895
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries J.M. Reyes; M.V. Gutierrez; H. Madariaga; W. Otero; R. Guzman; J. Izquierdo; M. Abello; P. Velez; D. Castillo; D. Ponce de Leon; T. Lukic; L. Amador;
Reumatol Clin. 2023;19:319-27